| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |